Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Johnson and Johnson under FBI scanner over possibilities of surgical device power morcellator spread

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media PackNow

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

ARPA-H Launches IGoR Program for AI...

The Advanced Research Projects Agency for Health has officially...

Medline Launches AI-Powered Supply Chain Platform...

Medline Industries has unveiled a new artificial intelligence-driven supply...

DOJ Launches West Coast Strike Force...

The United States Department of Justice has launched a...

The FBI is investigating whether Johnson and Johnson was aware that a surgical device it manufactured could spread cancer in the women on whom it is used.
The FBI is investigating whether Johnson and Johnson was aware that a surgical device it manufactured could spread cancer in the women on whom it is used.
Johnson and Johnson is one of the leading manufacturers of the power morcellator — a surgical device that breaks down growths in the uterus so that they can be easily removed. However, in as many as one out of every 350 cases, an unknown cancer is hidden within growths, and the device could potentially worsen the condition.
Johnson and Johnson may have been alerted to to the risks as early as 2006. The company didn’t remove the device from the market, however, until July 2014. In November of that year, the U.S. Food and Drug Administration implemented its most serious warning on the device.
In that FDA warning, the agency noted that the device could “significantly [worsen] the patient’s long-term survival.”
The agency urged against the use of power morcellators.

 

MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

ARPA-H Launches IGoR Program for AI in Biomedical Research

The Advanced Research Projects Agency for Health has officially...

Medline Launches AI-Powered Supply Chain Platform in Partnership with Microsoft

Medline Industries has unveiled a new artificial intelligence-driven supply...

AI Emergency Triage Study Shows Superior Clinical Accuracy

A Harvard-led study has found that advanced artificial intelligence...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป